Verilumia 
FDA Approves Oral Drug That Doubles Pancreatic Cancer Survival
The U.S. Food and Drug Administration on Wednesday approved Rasonque, a first-of-its-kind oral medication for advanced pancreatic cancer, marking a significant breakthrough in treating one of the deadliest forms of the d...
